News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
29-Sep-2006 - A jumping gene first identified in a cabbage-eating moth may one day provide a safer, target-specific alternative to viruses for gene therapy, researchers say. They compared the ability of the four best-characterized jumping genes, or transposons, to insert themselves into a cell's DNA and ...
03-Aug-2006 - VASTox plc has provided a grant to the UK muscular dystrophy charity, Parent Project UK (PPUK), to support the development and management of its Duchenne muscular dystrophy (DMD) patient registry. The DMD Registry aims to register every person in the UK with DMD and Becker muscular ...
31-Mar-2006 - A Jackson Laboratory associate staff scientist has found a mouse model with a previously unknown genetic defect that causes a kind of muscular dystrophy (MD). The finding could shed light on some human MD cases for which a specific genetic link has not been established. For many people, the term ...
10-Mar-2006 - Crucell N.V. and allied contract manufacturer DSM Biologics announced that they have signed a PER.C6® research license agreement with Japanese pharmaceutical company UMN Pharma. This license agreement allows UMN Pharma to use the PER.C6® cell line in its 'UMN-03' project, which aims to employ a ...
26-Jan-2006 - VASTox, a chemical genomics company, announced promising results from its lead preclinical development programme for Duchenne Muscular Dystrophy ("DMD"). DMD is a devastating disease that affects young males for which there is currently no effective treatment. For the first time, VASTox has ...
16-Dec-2005 - Santhera Pharmaceuticals AG announced that it has started a European Phase III clinical study with its lead product SNT-MC17 (idebenone) in Friedreich's Ataxia (FRDA). The design of this study reflects the company's discussions with EMEA which took place earlier this year and will evaluate both ...
SNT-MC17 (idebenone) enters Phase IIa study in Duchenne muscular dystrophy
21-Oct-2005 - Santhera Pharmaceuticals AG announced that it has started a Phase IIa clinical study with its lead product SNT-MC17 (idebenone) to evaluate its benefits in the treatment of Duchenne muscular dystrophy (DMD). DMD is the most common and devastating type of muscular dystrophy, causing weakness and ...
Bone marrow-derived cells fail to meet high expectations says Bonn study
05-Aug-2005 - Adult stem cells taken from bone marrow are the "shooting stars" of their field. Many research scientists have been speculating that the cells might be able to pass through the blood into diseased organs and replace defective tissue. Such cells are seen as the potential key to the treatment of ...
31-Mar-2005 - Gene therapy methods that specifically target muscle may reverse the symptoms of a rare form of muscular dystrophy, according to new research in mice conducted by medical geneticists at Duke University Medical Center. Infants born with the inherited muscular disorder called Pompe disease usually ...
25-Feb-2005 - Wyeth Pharmaceuticals, a division of Wyeth, will examine the safety of its novel investigational recombinant antibody MYO-029 in a phase one/two clinical trial in adult patients with muscular dystrophy (MD). The trial is open to adult patients with facioscapulohumeral MD (FSHD), Becker MD (BMD) ...
© 1997-2024 LUMITOS AG, All rights reserved